Cargando…

The Prognostic, Diagnostic, and Therapeutic Potential of TRAIL Signalling in Cardiovascular Diseases

TNF-related apoptosis-inducing ligand (TRAIL) was originally discovered, almost 20 years ago, for its ability to kill cancer cells. More recent evidence has described pleiotropic functions, particularly in the cardiovascular system. There is potential for TRAIL concentrations in the circulation to a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kelland, Elaina, Patil, Manisha S., Patel, Sanjay, Cartland, Siân P., Kavurma, Mary M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095395/ https://www.ncbi.nlm.nih.gov/pubmed/37047698 http://dx.doi.org/10.3390/ijms24076725

Ejemplares similares

TRAIL signals, extracellular matrix and vessel remodelling
por: Patil, Manisha S, et al.
Publicado: (2020)

TRAIL Deficiency Contributes to Diabetic Nephropathy in Fat-Fed ApoE(-/-) Mice
por: Cartland, Siân P., et al.
Publicado: (2014)

Comparative Evaluation of TRAIL, FGF-2 and VEGF-A-Induced Angiogenesis In Vitro and In Vivo
por: Cartland, Siân P., et al.
Publicado: (2016)

TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL
por: Di Bartolo, Belinda A., et al.
Publicado: (2013)

Correction: TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL
por: Di Bartolo, Belinda A., et al.
Publicado: (2013)

NADPH Oxidases, Angiogenesis, and Peripheral Artery Disease
por: Manuneedhi Cholan, Pradeep, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice
por: Cartland, Siân P., et al.
Publicado: (2017)

TRAIL-Expressing Monocyte/Macrophages Are Critical for Reducing Inflammation and Atherosclerosis
por: Cartland, Siân P., et al.
Publicado: (2019)

Tumor Necrosis Factor–Related Apoptosis‐Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia‐Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide–Dependent Mechanisms
por: Di Bartolo, Belinda Ann, et al.
Publicado: (2015)

Endothelial cell dysfunction: Implications for the pathogenesis of peripheral artery disease
por: Kavurma, Mary M., et al.
Publicado: (2022)

β (3) Adrenergic Receptor Stimulation Promotes Reperfusion in Ischemic Limbs in a Murine Diabetic Model
por: Bubb, Kristen J., et al.
Publicado: (2021)

HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis
por: Di Bartolo, Belinda A., et al.
Publicado: (2021)

The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases
por: Sygitowicz, Grażyna, et al.
Publicado: (2021)

A Nanoparticle-Based Affinity Sensor that Identifies and Selects Highly Cytokine-Secreting Cells
por: Liu, Guozhen, et al.
Publicado: (2019)

Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
por: Dutka, Mieczysław, et al.
Publicado: (2021)

Therapeutic targeting of TRAIL death receptors
por: Di Cristofano, Francesca, et al.
Publicado: (2023)

Expression of TRAIL-splice variants in gastric carcinomas: identification of TRAIL-γ as a prognostic marker
por: Krieg, Andreas, et al.
Publicado: (2013)

Mural Cells: Potential Therapeutic Targets to Bridge Cardiovascular Disease and Neurodegeneration
por: Lin, Alexander, et al.
Publicado: (2021)

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease
por: Bernardi, Stella, et al.
Publicado: (2016)

The regulation of combined treatment-induced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells
por: Ryu, Sunhyo, et al.
Publicado: (2018)

Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction
por: Secchiero, Paola, et al.
Publicado: (2009)

Selenomethionine supplementation reduces lesion burden, improves vessel function and modulates the inflammatory response within the setting of atherosclerosis
por: Zhang, Yunjia, et al.
Publicado: (2019)

MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential
por: Wani, Javaid Ahmad, et al.
Publicado: (2022)

Role of Extracellular Vesicles as Potential Diagnostic and/or Therapeutic Biomarkers in Chronic Cardiovascular Diseases
por: Martin-Ventura, Jose Luis, et al.
Publicado: (2022)

Potential Diagnostic and Prognostic Biomarkers of Epigenetic Drift within the Cardiovascular Compartment
por: Wallace, Robert G., et al.
Publicado: (2016)

TRAIL-based gene delivery and therapeutic strategies
por: Zhong, Hui-hai, et al.
Publicado: (2019)

Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies
por: Parsai, Chirine, et al.
Publicado: (2012)

TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?
por: Bernardi, Stella, et al.
Publicado: (2019)

Cold PSM, but not TRAIL, triggers autophagic cell death: A therapeutic advantage of PSM over TRAIL
por: Ito, Tomohisa, et al.
Publicado: (2018)

Assessment of concentrations of sTRAIL ligand and its receptors sTRAIL-R1 and sTRAIL-R2 – markers monitoring the course of the extrinsic pathway of apoptosis induction: potential application in ovarian cancer diagnostics
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2015)

Therapeutic Potential of Oxytocin in Atherosclerotic Cardiovascular Disease: Mechanisms and Signaling Pathways
por: Wang, Ping, et al.
Publicado: (2019)

Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
por: Trivedi, Rachana, et al.
Publicado: (2015)

Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases
por: Mu, Danni, et al.
Publicado: (2022)

Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases
por: Song, Jialin, et al.
Publicado: (2017)

Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System
por: Toffoli, Barbara, et al.
Publicado: (2016)

Regulation of TRAIL expression by PRAME and EZH2 as potential therapeutic target against solid tumors
por: Mello, Barbara P, et al.
Publicado: (2013)

TRAIL-β and TRAIL-γ: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potential
por: Krieg, A, et al.
Publicado: (2003)

TRAIL signaling promotes entosis in colorectal cancer
por: Bozkurt, Emir, et al.
Publicado: (2021)

TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic “Achilles heel” for the TrkAIII oncoprotein in neuroblastoma
por: Gneo, Luciana, et al.
Publicado: (2016)

Potential diagnostics and therapeutic approaches in COVID-19
por: Kumari, Pratibha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nvc3sllr7o2e4du23te7dgcd04